Study finds 86% of cannabis products lack required label info
A Medical Xpress-reported analysis says most products on shelves omit legally required label details, raising compliance and consumer-safety questions for operators and regulators alike.

Artisan coffee bags neatly arranged on rustic shelves in a cozy shop setting.
The headline number: 86% of products fell short
Medical Xpress reported on Nov. 12 that 86% of cannabis products in a new analysis were missing information their states require on the label.
That's a failure rate no operator wants attached to the category. The coverage points to a gap between what regulators demand on paper and what actually reaches the shelf.
Here's what we have: a headline and a summary link, not the underlying paper. We haven't independently reviewed the study's methodology, sample size, jurisdictions covered or the specific data fields it counted as missing. Those details determine how far the 86% figure generalizes. We won't guess at them.
Why a figure like this matters to operators
When a majority of products fail a labeling audit, the risk shifts from individual bad actors to a systemic compliance problem that regulators can no longer treat as an outlier.
Labeling rules sit at the center of state cannabis programs. They typically govern potency, ingredients, warnings, batch identifiers and testing information. Missing fields can trigger administrative penalties, stop-sale orders and recalls, and they undercut the consumer-protection case that legal markets rely on to keep public trust.
The cleanest read on this number is that it's an enforcement signal. A statistic this stark hands agencies like California's Department of Cannabis Control and Colorado's Marijuana Enforcement Division a ready-made rationale for tighter audits. Legislators in states still writing rules get a talking point, too.
A label failure rate this high suggests the problem sits in the process of how products get labeled, not just in a few careless brands.
What to watch next
The practical question is whether regulators respond with guidance, targeted inspections or penalties, and whether the study's authors detail which label elements were most often missing.
For multistate operators and single-license shops alike, the immediate move is an internal label audit against current state rules, ideally before an inspector runs one for them. Brands that sell across state lines carry an added burden. Tracking differing requirements is where omissions tend to creep in.
For full background on how labeling rules are written and enforced, see the CannIntel topic hub on cannabis product labeling and compliance. Consumers, meanwhile, should treat a missing potency or testing field as a reason to ask questions at the counter.
The next signal: publication of the full study, and any regulator statement in response.
Frequently asked questions
What did the study find about cannabis labels?
According to a Nov. 12 Medical Xpress report, 86% of cannabis products examined lacked information their labels are required to carry. The summary available does not specify which fields were missing or which states were sampled.
What information is typically required on a cannabis label?
Requirements vary by state but commonly include potency, ingredients, health warnings, batch or lot identifiers and testing details. Operators should check their own state regulator's current rules for the exact list.
What are the consequences of noncompliant cannabis labeling?
Penalties depend on the state but can include fines, stop-sale orders and product recalls. Widespread noncompliance also increases the likelihood of tighter audits and rulemaking.
Has CannIntel verified the 86% figure?
No. CannIntel reviewed the Medical Xpress headline and summary, not the underlying paper. Sample size, jurisdictions and the definition of required information remain unconfirmed.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

First Phase of Federal Hemp Product Ban Takes Effect
The first phase of a renewed federal ban on intoxicating hemp products is now in force, and industry groups are lobbying Congress for a regulatory alternative.

Missouri Law Tightening Marijuana, Hemp Rules Takes Effect
A new Missouri statute reshaping the state's marijuana and hemp regulatory framework is now in force, though the signal supplies few operational specifics.

IOL: Positive dagga test doesn't prove impairment at work
A South African workplace-testing report says a positive cannabis result shows past use, not on-the-job impairment, a gap that matters for employers acting on it.
More from the newsroom

Brazil's Medical Cannabis Market Hits $90M a Year as Prescriptions Surge
High Times reports Brazil's prescription-driven medical cannabis market has reached roughly $90 million annually, but the signal leaves key tax and regulatory questions unanswered.

Joe Rogan Blames Texas GOP's Hemp THC Ban for Midterm Losses
The Austin-based podcaster said Republicans 'fucked up' by pushing to ban hemp-derived THC products, tying a culture-war fight to last week's election results.

Attorney Casey Leaver to Detail Cannabis Packaging Pitfalls at MJBizCon
A single label rarely satisfies every jurisdiction, and attorney Casey Leaver plans to walk operators through the compliance mistakes exposing them and retailers to risk.